Trinity Biotech reported 7.09M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 3042M 769M
Bayer BAYN:GR € 2089M 946M
Bio Rad Laboratories BIO:US $ 196.9M 46.12M
Cytori Therapeutics CYTX:US $ -3.39M 0.91M
Johnson & Johnson JNJ:US $ 8192M 2043M
Mesa Laboratories MLAB:US $ 8.48M 783K
Oxford Immunotec Global OXFD:US $ 0.79M 10.16M
Siemens SIE:GR € 2519M 58M
Sientra SIEN:US $ -10.66M 2.22M
Surmodics SRDX:US $ 2.51M 2.58M
Thermo Fisher Scientific TMO:US $ 2924M 24M
Trinity Biotech TRIB:US 7.09M 3.21M
Veracyte VCYT:US $ -36.04M 41.77M